Geneos Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-238	Closed	-$77.6K	–	2495
2025 Q2	$77.6K	Sell	238 -221	-48%	-$61.2K	﹤0.01%	1359
2025 Q1	$124K	Buy	459 +412	+877%	+$106K	﹤0.01%	1445
2024 Q4	$11.1K	Hold	47	–	–	﹤0.01%	2013
2024 Q3	$12.9K	Buy	+47	New	+$12.2K	﹤0.01%	1729
2022 Q3	–	Sell	-986	Closed	-$146K	–	2016
2022 Q2	$146K	Sell	986 -679	-41%	-$96.3K	0.01%	864
2022 Q1	$271K	Sell	1,665 -58	-3%	-$8.84K	0.01%	697
2021 Q4	$292K	Buy	1,723 +37	+2%	+$6.88K	0.01%	741
2021 Q3	$324K	Buy	1,686 +3	+0.2%	+$563	0.01%	683
2021 Q2	$288K	Sell	1,683 -103	-6%	-$15.1K	0.01%	706
2021 Q1	$251K	Sell	1,786 -224	-11%	-$33.7K	0.01%	877
2020 Q4	$276K	Buy	+2,010	New	+$268K	0.01%	714
2017 Q2	–	Sell	-24	Closed	-$1K	–	2070
2017 Q1	$1K	Sell	24 -18	-43%	-$832	﹤0.01%	1957
2016 Q4	$1K	Hold	42	–	–	﹤0.01%	1921
2016 Q3	$2K	Buy	+42	New	+$2.96K	﹤0.01%	1741